George Soros's position in Day One Biopharmaceuticals is currently worth $33.1M. That's 0.38% of their equity portfolio (46th largest holding). The investor owns 1.49% of the outstanding Day One Biopharmaceuticals stock. The stake costed the investor $20.8M, netting the investor a gain of 59% so far.